Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme

In this study, we demonstrate that Raman microscopy combined with computational analysis is a useful approach to discriminating accurately between brain tumor bio-specimens and to identifying structural changes in glioblastoma (GBM) bio-signatures after nordihydroguaiaretic acid (NDGA) administratio...

Full description

Bibliographic Details
Main Authors: Felicia S. Manciu, Jose Guerrero, Kevin E. Bennet, Su-Youne Chang, Masum Rahman, Lizbeth V. Martinez Lopez, Siobhan Chantigian, Mariana Castellanos, Marian Manciu
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/22/7/2643
_version_ 1797437710842986496
author Felicia S. Manciu
Jose Guerrero
Kevin E. Bennet
Su-Youne Chang
Masum Rahman
Lizbeth V. Martinez Lopez
Siobhan Chantigian
Mariana Castellanos
Marian Manciu
author_facet Felicia S. Manciu
Jose Guerrero
Kevin E. Bennet
Su-Youne Chang
Masum Rahman
Lizbeth V. Martinez Lopez
Siobhan Chantigian
Mariana Castellanos
Marian Manciu
author_sort Felicia S. Manciu
collection DOAJ
description In this study, we demonstrate that Raman microscopy combined with computational analysis is a useful approach to discriminating accurately between brain tumor bio-specimens and to identifying structural changes in glioblastoma (GBM) bio-signatures after nordihydroguaiaretic acid (NDGA) administration. NDGA phenolic lignan was selected as a potential therapeutic agent because of its reported beneficial effects in alleviating and inhibiting the formation of multi-organ malignant tumors. The current analysis of NDGA’s impact on GBM human cells demonstrates a reduction in the quantity of altered protein content and of reactive oxygen species (ROS)-damaged phenylalanine; results that correlate with the ROS scavenger and anti-oxidant properties of NDGA. A novel outcome presented here is the use of phenylalanine as a biomarker for differentiating between samples and assessing drug efficacy. Treatment with a low NDGA dose shows a decline in abnormal lipid-protein metabolism, which is inferred by the formation of lipid droplets and a decrease in altered protein content. A very high dose results in cell structural and membrane damage that favors transformed protein overexpression. The information gained through this work is of substantial value for understanding NDGA’s beneficial as well as detrimental bio-effects as a potential therapeutic drug for brain cancer.
first_indexed 2024-03-09T11:25:15Z
format Article
id doaj.art-5b68cc0ca1124144a5a7feba94a66722
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-03-09T11:25:15Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-5b68cc0ca1124144a5a7feba94a667222023-12-01T00:02:39ZengMDPI AGSensors1424-82202022-03-01227264310.3390/s22072643Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma MultiformeFelicia S. Manciu0Jose Guerrero1Kevin E. Bennet2Su-Youne Chang3Masum Rahman4Lizbeth V. Martinez Lopez5Siobhan Chantigian6Mariana Castellanos7Marian Manciu8Department of Physics, University of Texas at El Paso, El Paso, TX 79968, USADepartment of Physics, University of Texas at El Paso, El Paso, TX 79968, USADepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USADepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USADepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USADepartment of Physics, University of Texas at El Paso, El Paso, TX 79968, USADepartment of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USADepartment of Physics, University of Texas at El Paso, El Paso, TX 79968, USADepartment of Physics, University of Texas at El Paso, El Paso, TX 79968, USAIn this study, we demonstrate that Raman microscopy combined with computational analysis is a useful approach to discriminating accurately between brain tumor bio-specimens and to identifying structural changes in glioblastoma (GBM) bio-signatures after nordihydroguaiaretic acid (NDGA) administration. NDGA phenolic lignan was selected as a potential therapeutic agent because of its reported beneficial effects in alleviating and inhibiting the formation of multi-organ malignant tumors. The current analysis of NDGA’s impact on GBM human cells demonstrates a reduction in the quantity of altered protein content and of reactive oxygen species (ROS)-damaged phenylalanine; results that correlate with the ROS scavenger and anti-oxidant properties of NDGA. A novel outcome presented here is the use of phenylalanine as a biomarker for differentiating between samples and assessing drug efficacy. Treatment with a low NDGA dose shows a decline in abnormal lipid-protein metabolism, which is inferred by the formation of lipid droplets and a decrease in altered protein content. A very high dose results in cell structural and membrane damage that favors transformed protein overexpression. The information gained through this work is of substantial value for understanding NDGA’s beneficial as well as detrimental bio-effects as a potential therapeutic drug for brain cancer.https://www.mdpi.com/1424-8220/22/7/2643Raman microscopyopticalstatistical analysisprincipal component analysisglioblastoma cellsnordihydroguaiaretic acid
spellingShingle Felicia S. Manciu
Jose Guerrero
Kevin E. Bennet
Su-Youne Chang
Masum Rahman
Lizbeth V. Martinez Lopez
Siobhan Chantigian
Mariana Castellanos
Marian Manciu
Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
Sensors
Raman microscopy
optical
statistical analysis
principal component analysis
glioblastoma cells
nordihydroguaiaretic acid
title Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
title_full Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
title_fullStr Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
title_full_unstemmed Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
title_short Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
title_sort assessing nordihydroguaiaretic acid therapeutic effect for glioblastoma multiforme
topic Raman microscopy
optical
statistical analysis
principal component analysis
glioblastoma cells
nordihydroguaiaretic acid
url https://www.mdpi.com/1424-8220/22/7/2643
work_keys_str_mv AT feliciasmanciu assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT joseguerrero assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT kevinebennet assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT suyounechang assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT masumrahman assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT lizbethvmartinezlopez assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT siobhanchantigian assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT marianacastellanos assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme
AT marianmanciu assessingnordihydroguaiareticacidtherapeuticeffectforglioblastomamultiforme